Abstract:
Inflammation and its mediators have an important role in gingivitis and periodontitis. Prostaglandin is one of
the eicosanoid involved in many chronic inflammatory diseases, including periodontal diseases. Aspirin irreversibly
acetylates cyclooxygenase and inactivate this enzyme responsible for the production of PGE2 that mediates pain and
inflammation. The aim of the study was to prepare aspirin gel and mouthwash in 1% concentration and use it in patients
with periodontal diseases during the non-surgical periodontal treatment and to assess its anti-inflammatory effects on
salivary biomarkers PGE2, TNF-α, and nitric oxide. Thirty patients were divided into three treatment groups, standard
treatment group, second received scaling and root planning with gel application of 1% aspirin, third received scaling and
root planning followed by rinsing with 1% aspirin mouthwash. Results indicated that the levels of PGE2, TNF-α and
nitric oxide in the groups of patients received gel treatment and mouthwash treatment was decreased to significant levels
(p≤ 0.001) as compared to the group of standard treatment. Aspirin gel was found to be more effective in reducing
inflammatory biomarkers in contrast to aspirin mouthwash (p≤0.001). We concluded from our study, that low
concentration of aspirin oral preparations are highly active in reducing the inflammatory biomarkers associated with
periodontal diseases.
